Different from the above NPs, Isorhamnetin (ISO) demonstrates an inhibitory effect on autophagy in treating GC by targeting the PI3K/AKT/mTOR pathway to reverse hypoxia-induced protective autophagy in MKN-28 cells and promote mitochondria-mediated cell apoptosis. Here, PIK3CA is linked to gastric cancer.